Consistent with the RNA-seq prediction and the previous findings in a subset of TARGET osteosarcoma cohort (Wunder et al., 2020), there were robust infiltrating T cells (markers CD3, CD8) and M2 macrophages (CD163), with moderate PD-L1 expression in these osteosarcoma samples (Figure S4). Here, CD163 is linked to osteosarcoma.